Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 May 2022 for Virpax Pharmaceuticals, Inc..
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Eric Floyd: trading record in brief
One trade, one date: on 20 May 2022, Eric Floyd disclosed an open-market purchase of €5,831 in Virpax Pharmaceuticals, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Floyd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 4,479 shares@ €1.302100.0% of flowCommon Stock, $0.00001 par valueSEC:0001493152-22-014657:0Canonical exit: 16 Aug 2022 (T+90)
1 of 1 declaration